Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$38.85
2.226.06%
At close: -
$37.96
-0.89-2.29%
After Hours: 5:00 PM EDT
Comments
Loading...
Twist Bioscience Analyst Ratings and Price Targets | NASDAQ:TWST | Benzinga
Twist Bioscience Corp has a consensus price target of $46.86 based on the ratings of 14 analysts. The high is $62 issued by Scotiabank on February 4, 2025. The low is $27 issued by Berenberg on September 27, 2023. The 3 most-recent analyst ratings were released by Barclays, Scotiabank, and JP Morgan on April 10, 2025, February 4, 2025, and February 4, 2025, respectively. With an average price target of $49 between Barclays, Scotiabank, and JP Morgan, there's an implied 29.08% upside for Twist Bioscience Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Barclays
Scotiabank
JP Morgan
Baird
Wolfe Research
1calculated from analyst ratings
Analyst Ratings for Twist Bioscience
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/10/2025 | Buy Now | 18.55% | Barclays | Luke Sergott51% | $58 → $45 | Maintains | Overweight | Get Alert |
| 02/04/2025 | Buy Now | 63.33% | Scotiabank | Sung Ji Nam46% | $54 → $62 | Maintains | Sector Outperform | Get Alert |
| 02/04/2025 | Buy Now | 5.37% | JP Morgan | Rachel Vatnsdal60% | $35 → $40 | Maintains | Underweight | Get Alert |
| 02/04/2025 | Buy Now | 42.26% | Baird | Catherine Ramsey53% | $48 → $54 | Maintains | Outperform | Get Alert |
| 12/13/2024 | Buy Now | 58.06% | Wolfe Research | Doug Schenkel70% | → $60 | Initiates | → Outperform | Get Alert |
| 11/26/2024 | Buy Now | 52.79% | TD Cowen | Steven Mah50% | $58 → $58 | Reiterates | Buy → Buy | Get Alert |
| 11/19/2024 | Buy Now | 36.99% | Barclays | Luke Sergott51% | $55 → $52 | Maintains | Overweight | Get Alert |
| 11/19/2024 | Buy Now | 42.26% | Scotiabank | Sung Ji Nam46% | $50 → $54 | Maintains | Sector Outperform | Get Alert |
| 11/19/2024 | Buy Now | 26.45% | Baird | Catherine Ramsey53% | $46 → $48 | Maintains | Outperform | Get Alert |
| 10/17/2024 | Buy Now | 26.45% | Leerink Partners | — | $45 → $48 | Maintains | Market Perform | Get Alert |
| 10/01/2024 | Buy Now | 47.52% | Evercore ISI Group | Vijay Kumar50% | $52 → $56 | Maintains | Outperform | Get Alert |
| 08/05/2024 | Buy Now | 44.89% | Barclays | Luke Sergott51% | $60 → $55 | Maintains | Overweight | Get Alert |
| 08/05/2024 | Buy Now | -7.8% | JP Morgan | Tycho Peterson82% | $28 → $35 | Maintains | Underweight | Get Alert |
| 08/05/2024 | Buy Now | 21.18% | Baird | Catherine Ramsey53% | $40 → $46 | Maintains | Outperform | Get Alert |
| 07/09/2024 | Buy Now | 44.89% | Goldman Sachs | Matthew Sykes65% | $45 → $55 | Maintains | Buy | Get Alert |
| 06/28/2024 | Buy Now | 58.06% | Barclays | Luke Sergott51% | $45 → $60 | Maintains | Overweight | Get Alert |
| 06/13/2024 | Buy Now | 71.23% | TD Cowen | Steven Mah50% | $55 → $65 | Maintains | Buy | Get Alert |
| 06/05/2024 | Buy Now | 39.62% | Guggenheim | Subbu Nambi35% | → $53 | Initiates | → Buy | Get Alert |
| 05/06/2024 | Buy Now | 26.45% | Scotiabank | Sung Ji Nam46% | $43 → $48 | Maintains | Sector Outperform | Get Alert |
| 05/03/2024 | Buy Now | 31.72% | Evercore ISI Group | Vijay Kumar50% | $46 → $50 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | 18.55% | Barclays | Luke Sergott51% | $40 → $45 | Maintains | Overweight | Get Alert |
| 05/03/2024 | Buy Now | 5.37% | Baird | Catherine Ramsey53% | $39 → $40 | Maintains | Outperform | Get Alert |
| 04/10/2024 | Buy Now | 5.37% | Barclays | Luke Sergott51% | $45 → $40 | Maintains | Overweight | Get Alert |
| 02/05/2024 | Buy Now | 13.28% | Scotiabank | Sung Ji Nam46% | $30 → $43 | Maintains | Sector Outperform | Get Alert |
| 01/25/2024 | Buy Now | 18.55% | Barclays | Luke Sergott51% | $30 → $45 | Maintains | Overweight | Get Alert |
| 01/18/2024 | Buy Now | 18.55% | Goldman Sachs | Matthew Sykes65% | $25 → $45 | Maintains | Buy | Get Alert |
| 01/17/2024 | Buy Now | 18.55% | Goldman Sachs | Matthew Sykes65% | $25 → $45 | Upgrade | Neutral → Buy | Get Alert |
| 09/27/2023 | Buy Now | -28.87% | Berenberg | Gaurav Goparaju25% | → $27 | Initiates | → Buy | Get Alert |
| 08/07/2023 | Buy Now | -31.51% | Barclays | Luke Sergott51% | $20 → $26 | Maintains | Overweight | Get Alert |
| 07/13/2023 | Buy Now | -47.31% | Goldman Sachs | Matthew Sykes65% | $18 → $20 | Maintains | Neutral | Get Alert |
| 05/08/2023 | Buy Now | -52.58% | Baird | Catherine Ramsey53% | $29 → $18 | Maintains | Outperform | Get Alert |
| 05/08/2023 | Buy Now | -47.31% | Barclays | Luke Sergott51% | $32 → $20 | Maintains | Overweight | Get Alert |
| 04/19/2023 | Buy Now | -47.31% | Goldman Sachs | Matthew Sykes65% | $43 → $20 | Maintains | Neutral | Get Alert |
| 04/18/2023 | Buy Now | -47.31% | Goldman Sachs | Matthew Sykes65% | $43 → $20 | Maintains | Neutral | Get Alert |
| 02/06/2023 | Buy Now | 13.28% | Goldman Sachs | Matthew Sykes65% | $50 → $43 | Maintains | Neutral | Get Alert |
| 02/06/2023 | Buy Now | -23.6% | Baird | Catherine Ramsey53% | $33 → $29 | Maintains | Outperform | Get Alert |
| 02/06/2023 | Buy Now | -15.7% | Barclays | Luke Sergott51% | $37 → $32 | Maintains | Overweight | Get Alert |
| 01/30/2023 | Buy Now | -2.53% | Barclays | Luke Sergott51% | $43 → $37 | Maintains | Overweight | Get Alert |
| 01/05/2023 | Buy Now | -13.07% | Scotiabank | Sung Ji Nam46% | → $33 | Initiates | → Sector Outperform | Get Alert |
| 01/03/2023 | Buy Now | -5.16% | Evercore ISI Group | Vijay Kumar50% | $28 → $36 | Upgrade | In-Line → Outperform | Get Alert |
| 11/21/2022 | Buy Now | -13.07% | Baird | Catherine Schulte68% | $56 → $33 | Maintains | Outperform | Get Alert |
| 11/21/2022 | Buy Now | 13.28% | Barclays | Luke Sergott51% | $45 → $43 | Maintains | Overweight | Get Alert |
| 11/21/2022 | Buy Now | -20.97% | SVB Leerink | Puneet Souda58% | $45 → $30 | Maintains | Market Perform | Get Alert |
| 10/07/2022 | Buy Now | 18.55% | SVB Leerink | Puneet Souda58% | $50 → $45 | Maintains | Market Perform | Get Alert |
| 10/06/2022 | Buy Now | 18.55% | Barclays | Luke Sergott51% | $55 → $45 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 44.89% | Barclays | Luke Sergott51% | $45 → $55 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 31.72% | SVB Leerink | Puneet Souda58% | $45 → $50 | Maintains | Market Perform | Get Alert |
| 07/13/2022 | Buy Now | 18.55% | Barclays | Luke Sergott51% | $40 → $45 | Maintains | Overweight | Get Alert |
| 05/09/2022 | Buy Now | 5.37% | Barclays | Luke Sergott51% | $60 → $40 | Maintains | Overweight | Get Alert |
| 04/13/2022 | Buy Now | 44.89% | Goldman Sachs | Matthew Sykes65% | $105 → $55 | Maintains | Neutral | Get Alert |
FAQ
What is the target price for Twist Bioscience (TWST) stock?
The latest price target for Twist Bioscience (NASDAQ:TWST) was reported by Barclays on April 10, 2025. The analyst firm set a price target for $45.00 expecting TWST to rise to within 12 months (a possible 18.55% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Twist Bioscience (TWST)?
The latest analyst rating for Twist Bioscience (NASDAQ:TWST) was provided by Barclays, and Twist Bioscience maintained their overweight rating.
When was the last upgrade for Twist Bioscience (TWST)?
The last upgrade for Twist Bioscience Corp happened on January 17, 2024 when Goldman Sachs raised their price target to $45. Goldman Sachs previously had a neutral for Twist Bioscience Corp.
When was the last downgrade for Twist Bioscience (TWST)?
There is no last downgrade for Twist Bioscience.
When is the next analyst rating going to be posted or updated for Twist Bioscience (TWST)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Twist Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Twist Bioscience was filed on April 10, 2025 so you should expect the next rating to be made available sometime around April 10, 2026.
Is the Analyst Rating Twist Bioscience (TWST) correct?
While ratings are subjective and will change, the latest Twist Bioscience (TWST) rating was a maintained with a price target of $58.00 to $45.00. The current price Twist Bioscience (TWST) is trading at is $37.96, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.